Company news
Biostax Corp. news in 2015
Biostax Corp.'s news releases, calls and decks from 2015, newest first.
Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.
May 4, 2015
ClearTrust, LLC is Immune Therapeutics' New Transfer Agent and Support Provider
January 26, 2015
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc.
January 23, 2015
Immune Therapeutics, Inc. Announces Appointment of New Director and Acceptance of Election by Director
January 21, 2015
Immune Therapeutics Inc. Announces Appointment of New President and Chief Operating Officer
January 14, 2015
The Jack Brewer Foundation and Immune Therapeutics Inc. Announce Medical Equipment Donation Program for the Prevention of Cervical Cancer in Africa to be Unveiled Today at the United Nations
January 8, 2015
Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress
January 5, 2015